Table 1 Inhibitors in the drug screen and their targets

From: Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells

Inhibitor

Major target(s)

LY294002

PI3K/AKT

SB431542

TGFβR1

Gefitinib

EGFR

Dasatinib

BCR-Abl, Src

Rapamycin

mTOR

JNK inhibitor

JNK

PD98059

MEK

Palbociclib

CDK4/6

Back to article page